Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.

Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early ...

A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12 in a year to 1,172 drug-related deaths in 2023.

India is currently facing an unprecedented rise in Non-Communicable Diseases (NCDs) accounting for over 66 per cent of all ...

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Anna Podolanczuk, M.D., M.S., discusses how biomarker testing plays a role in diagnosing idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), helping to distinguish these ...